dr. timothy yap discusses an effective therapy for her2-negative breast cancer
Published 3 months ago • 180 plays • Length 3:50Download video MP4
Download video MP3
Similar videos
-
1:52
dr timothy yap: rucaparib/sacituzumab govitecan combo effective against triple-negative disease
-
1:17
dr timothy yap: parp/top1 inhibitor toxicities can be managed through targeted delivery
-
31:21
novel therapeutics for breast cancer: her2 and triple negative disease; new pathways, targets
-
1:23
dr timothy yap reiterates the unmet medical need for molecularly targeted agents in solid tumors
-
21:41
ms1 targeting dna damage response and hrd in breast cancer timothy a. yap
-
6:35
first-in-human results of cdk2/4/6 inhibition in breast and ovarian cancer
-
7:34
first-line therapy for hr-positive, her2-negative, mbc
-
6:04
breast cancer breakthroughs: treatment options for triple negative breast cancer
-
33:35
which metastatic breast cancer treatment is right for you? what you need to know
-
5:41
future directions for treatment of tnbc
-
5:38
tak-228 plus hormonal therapy for metastatic, er-positive/her2-negative breast cancer
-
50:22
treating metastatic breast cancer: the promise of precision medicine
-
1:10
iu researchers make breakthrough in breast cancer treatment
-
30:10
2022 ku post san antonio review | metastatic her2 positive breast cancer: novel treatment approaches
-
0:49
systemic therapies shown to be effective in her2-positive breast cancer
-
2:27
integrative medicine in the management of metastatic breast cancer
-
1:39
treatment for her2 metastatic breast cancer
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
31:24
124. metastatic her2- positive breast cancer